NT

Neha Tabassum

Active Director Director DIN 09499151
DIN 09499151 First appointment Feb 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2022
Shareholding value •••• Premium profile

About Neha Tabassum

Data last updated:

Neha Tabassum is a Director at Nutrica Pharma Private Limited (since 2022). The company operates in Healthcare. Nutrica Pharma Private Limited reported revenue of ₹3.9 Lakh (FY 2025).

DIN 09499151
Primary Designation Director
Industry Healthcare
First Appointment 09 Feb 2022
Oldest Company Age 4 yrs
Largest company Nutrica Pharma Private Limited · ₹3.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nutrica Pharma Private Limited U85100RJ2022PTC079579
Director09 Feb 20222022₹3.9 Lakh (FY 2025)Active

Board colleagues of Neha Tabassum

Directorship timeline

Open interactive timeline →
Nutrica Pharma Private Limited
Premium access

Shareholding and investment profile for Neha Tabassum

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neha Tabassum

Neha Tabassum currently holds 1 directorship: Nutrica Pharma Private Limited (Director, since 09 Feb 2022, revenue ₹3.9 Lakh (FY 2025)).

Neha Tabassum was first appointed on 09 Feb 2022 as Director at Nutrica Pharma Private Limited.

The current boards of Neha Tabassum's companies include Fahad Naque (Nutrica Pharma Private Limited), Mohammad Zarar Alam (Nutrica Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available